SPP1 and angiosarcoma: Hence, transcriptome analysis may elucidate molecular mechanisms underlying chemoresistance, as well as the role of SPP1 in angiosarcoma, aiding in the identification of novel biomarkers for targeted therapies for angiosarcoma.